Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30
Published June 21, 2023 · Recall initiated: June 12, 2023
Summary
FDA records drug Class III recall D-0871-2023, published June 21, 2023 and initiated June 12, 2023. Recalling firm: Amring Pharmaceuticals Inc; Status: Terminated; Reported quantity: 48,989 bottles; Lot: Lots: X220317A and X220318A, exp. date 09/25. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
What to do
Voluntary: Firm initiated · Letter
Get an email if TRANEXAMIC ACID has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TRANEXAMIC ACID
- Manufacturer
- Amring Pharmaceuticals Inc
- Distributor
- Nationwide in the USA.
- Lot
- Lots: X220317A and X220318A, exp. date 09/25
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski,June 21, 2023
- FDAIsopropyl Alcohol Antiseptic 75%, Topical Solution, Hand Sanitizer Non-sterile Solution, Volume: 3.785 L,June 21, 2023
- FDAAlinity i Anti-TPO Reagent Kit, List Number 09P3521June 14, 2023
- FDATrilogy Evo O2 EV300, Model Numbers DS2200X11B, IN2200X15B, FX2200X15B, CA2200X12B, FR2200X14B, ND2200X15B,June 14, 2023
- FDATranexamic Acid Injection, USP, 1000mg per 10 mL (100mg /mL), 10mL single-dose vial, Rx Only, Distributed by:October 12, 2022
- FDATranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10September 9, 2020
Questions about this recall
Was Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30 recalled?
Yes. FDA published recall D-0871-2023 on June 21, 2023. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TRANEXAMIC ACID.